Estimated Revenue:
$1M to $10M
Industry:
PharmTech
Technology:
Immunotherapy
Founded Date:
2005
Investor Type:
N/A
Headquarters:
New York, United States
Total Funding:
N/A
Employee Number:
11-50
Investment Stage:
N/A